SG Americas Securities
PROK icon

SG Americas Securities’s ProKidney PROK Stock Holding History

SG Americas Securities’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,870
Closed -$37K – 3527
2025
Q2 		$37K Buy
61,870
+35,342
+133% +$27.5K ﹤0.01% 2789
2025
Q1 		$23K Buy
+26,528
New +$36.8K ﹤0.01% 3366
2024
Q2 		– Sell
-13,511
Closed -$22K – 3220
2024
Q1 		$22K Sell
13,511
-33,318
-71% -$48.9K ﹤0.01% 2855
2023
Q4 		$83K Buy
46,829
+29,749
+174% +$63.8K ﹤0.01% 2817
2023
Q3 		$78K Buy
+17,080
New +$163K ﹤0.01% 2854

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SG Americas Securities's PROK Position: Q3 2025 in Review

SG Americas Securities sold out of ProKidney (PROK) in Q3 2025, closing a stake of 61,870 shares — an estimated $37K sold.

SG Americas Securities first reported a position in PROK in Q3 2023 and held it in 5 quarters. The position peaked at $83K in Q4 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q3 2025.

  • SG Americas Securities reported no remaining ProKidney position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 61,870 ProKidney shares in Q3 2025, an estimated $37K.
  • SG Americas Securities first reported a position in ProKidney in Q3 2023 and held it in 5 quarters.
  • SG Americas Securities's ProKidney position peaked at $83K in Q4 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.